ArticleFrontiers in pharmacology2021

Cost-Effectiveness of Adding SGLT2 Inhibitors to Standard Treatment for Heart Failure With Reduced Ejection Fraction Patients in China.

Yaohui Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.